Global PDE Inhibitors Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
The PDE Inhibitors market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global PDE Inhibitors market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Genitourinary accounting for % of the PDE Inhibitors global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While PDE5 segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of PDE Inhibitors include Hanmi Science Holding, Boehringer Ingelheim, Takeda Pharmaceuticals, AstraZeneca, and Bayer, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
PDE Inhibitors market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Chapter 1, to describe PDE Inhibitors product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of PDE Inhibitors, with price, sales, revenue and global market share of PDE Inhibitors from 2019 to 2022.
Chapter 3, the PDE Inhibitors competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the PDE Inhibitors breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and PDE Inhibitors market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of PDE Inhibitors.
Chapter 13, 14, and 15, to describe PDE Inhibitors sales channel, distributors, customers, research findings and conclusion, appendix and data source.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global PDE Inhibitors market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Genitourinary accounting for % of the PDE Inhibitors global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While PDE5 segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of PDE Inhibitors include Hanmi Science Holding, Boehringer Ingelheim, Takeda Pharmaceuticals, AstraZeneca, and Bayer, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
PDE Inhibitors market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
- PDE5
- PDE4
- Viagra
- Cialis
- Levitra
- Others
- Genitourinary
- Cardiovascular Diseases
- Dermatological Disorders
- Respiratory Diseases
- Schizophrenia
- Alzheimer’S Disease
- Huntington’S Disease
- Others
- Hanmi Science Holding
- Boehringer Ingelheim
- Takeda Pharmaceuticals
- AstraZeneca
- Bayer
- Celgene
- Eli Lilly
- Pfizer
- BioCrea
- Dart NeuroScience
- Carinopharm
- CTC Bio
- FORUM Pharmaceuticals
- Intra-Cellular Therapies
- Omeros Corporation
- Medimetriks Pharmaceuticals
- NuSirt Biopharma
- Palobiopharma
- Roivant Sciences
- Sagene Pharmaceuticals
- Tetra Discovery Partners
- Tritech Biopharm
- Otsuka
- Chiesi Farmaceutici
- Verona Pharma
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe PDE Inhibitors product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of PDE Inhibitors, with price, sales, revenue and global market share of PDE Inhibitors from 2019 to 2022.
Chapter 3, the PDE Inhibitors competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the PDE Inhibitors breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and PDE Inhibitors market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of PDE Inhibitors.
Chapter 13, 14, and 15, to describe PDE Inhibitors sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 MARKET OVERVIEW
1.1 PDE Inhibitors Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global PDE Inhibitors Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 PDE5
1.2.3 PDE4
1.2.4 Viagra
1.2.5 Cialis
1.2.6 Levitra
1.2.7 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global PDE Inhibitors Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Genitourinary
1.3.3 Cardiovascular Diseases
1.3.4 Dermatological Disorders
1.3.5 Respiratory Diseases
1.3.6 Schizophrenia
1.3.7 Alzheimer’S Disease
1.3.8 Huntington’S Disease
1.3.9 Others
1.4 Global PDE Inhibitors Market Size & Forecast
1.4.1 Global PDE Inhibitors Sales in Value (2017 & 2021 & 2028)
1.4.2 Global PDE Inhibitors Sales in Volume (2017-2028)
1.4.3 Global PDE Inhibitors Price (2017-2028)
1.5 Global PDE Inhibitors Production Capacity Analysis
1.5.1 Global PDE Inhibitors Total Production Capacity (2017-2028)
1.5.2 Global PDE Inhibitors Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 PDE Inhibitors Market Drivers
1.6.2 PDE Inhibitors Market Restraints
1.6.3 PDE Inhibitors Trends Analysis
2 MANUFACTURERS PROFILES
2.1 Hanmi Science Holding
2.1.1 Hanmi Science Holding Details
2.1.2 Hanmi Science Holding Major Business
2.1.3 Hanmi Science Holding PDE Inhibitors Product and Services
2.1.4 Hanmi Science Holding PDE Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Boehringer Ingelheim
2.2.1 Boehringer Ingelheim Details
2.2.2 Boehringer Ingelheim Major Business
2.2.3 Boehringer Ingelheim PDE Inhibitors Product and Services
2.2.4 Boehringer Ingelheim PDE Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Takeda Pharmaceuticals
2.3.1 Takeda Pharmaceuticals Details
2.3.2 Takeda Pharmaceuticals Major Business
2.3.3 Takeda Pharmaceuticals PDE Inhibitors Product and Services
2.3.4 Takeda Pharmaceuticals PDE Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 AstraZeneca
2.4.1 AstraZeneca Details
2.4.2 AstraZeneca Major Business
2.4.3 AstraZeneca PDE Inhibitors Product and Services
2.4.4 AstraZeneca PDE Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Bayer
2.5.1 Bayer Details
2.5.2 Bayer Major Business
2.5.3 Bayer PDE Inhibitors Product and Services
2.5.4 Bayer PDE Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Celgene
2.6.1 Celgene Details
2.6.2 Celgene Major Business
2.6.3 Celgene PDE Inhibitors Product and Services
2.6.4 Celgene PDE Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Eli Lilly
2.7.1 Eli Lilly Details
2.7.2 Eli Lilly Major Business
2.7.3 Eli Lilly PDE Inhibitors Product and Services
2.7.4 Eli Lilly PDE Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Pfizer
2.8.1 Pfizer Details
2.8.2 Pfizer Major Business
2.8.3 Pfizer PDE Inhibitors Product and Services
2.8.4 Pfizer PDE Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 BioCrea
2.9.1 BioCrea Details
2.9.2 BioCrea Major Business
2.9.3 BioCrea PDE Inhibitors Product and Services
2.9.4 BioCrea PDE Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Dart NeuroScience
2.10.1 Dart NeuroScience Details
2.10.2 Dart NeuroScience Major Business
2.10.3 Dart NeuroScience PDE Inhibitors Product and Services
2.10.4 Dart NeuroScience PDE Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Carinopharm
2.11.1 Carinopharm Details
2.11.2 Carinopharm Major Business
2.11.3 Carinopharm PDE Inhibitors Product and Services
2.11.4 Carinopharm PDE Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 CTC Bio
2.12.1 CTC Bio Details
2.12.2 CTC Bio Major Business
2.12.3 CTC Bio PDE Inhibitors Product and Services
2.12.4 CTC Bio PDE Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 FORUM Pharmaceuticals
2.13.1 FORUM Pharmaceuticals Details
2.13.2 FORUM Pharmaceuticals Major Business
2.13.3 FORUM Pharmaceuticals PDE Inhibitors Product and Services
2.13.4 FORUM Pharmaceuticals PDE Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Intra-Cellular Therapies
2.14.1 Intra-Cellular Therapies Details
2.14.2 Intra-Cellular Therapies Major Business
2.14.3 Intra-Cellular Therapies PDE Inhibitors Product and Services
2.14.4 Intra-Cellular Therapies PDE Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Omeros Corporation
2.15.1 Omeros Corporation Details
2.15.2 Omeros Corporation Major Business
2.15.3 Omeros Corporation PDE Inhibitors Product and Services
2.15.4 Omeros Corporation PDE Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Medimetriks Pharmaceuticals
2.16.1 Medimetriks Pharmaceuticals Details
2.16.2 Medimetriks Pharmaceuticals Major Business
2.16.3 Medimetriks Pharmaceuticals PDE Inhibitors Product and Services
2.16.4 Medimetriks Pharmaceuticals PDE Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17 NuSirt Biopharma
2.17.1 NuSirt Biopharma Details
2.17.2 NuSirt Biopharma Major Business
2.17.3 NuSirt Biopharma PDE Inhibitors Product and Services
2.17.4 NuSirt Biopharma PDE Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18 Palobiopharma
2.18.1 Palobiopharma Details
2.18.2 Palobiopharma Major Business
2.18.3 Palobiopharma PDE Inhibitors Product and Services
2.18.4 Palobiopharma PDE Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.19 Roivant Sciences
2.19.1 Roivant Sciences Details
2.19.2 Roivant Sciences Major Business
2.19.3 Roivant Sciences PDE Inhibitors Product and Services
2.19.4 Roivant Sciences PDE Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.20 Sagene Pharmaceuticals
2.20.1 Sagene Pharmaceuticals Details
2.20.2 Sagene Pharmaceuticals Major Business
2.20.3 Sagene Pharmaceuticals PDE Inhibitors Product and Services
2.20.4 Sagene Pharmaceuticals PDE Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.21 Tetra Discovery Partners
2.21.1 Tetra Discovery Partners Details
2.21.2 Tetra Discovery Partners Major Business
2.21.3 Tetra Discovery Partners PDE Inhibitors Product and Services
2.21.4 Tetra Discovery Partners PDE Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.22 Tritech Biopharm
2.22.1 Tritech Biopharm Details
2.22.2 Tritech Biopharm Major Business
2.22.3 Tritech Biopharm PDE Inhibitors Product and Services
2.22.4 Tritech Biopharm PDE Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.23 Otsuka
2.23.1 Otsuka Details
2.23.2 Otsuka Major Business
2.23.3 Otsuka PDE Inhibitors Product and Services
2.23.4 Otsuka PDE Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.24 Chiesi Farmaceutici
2.24.1 Chiesi Farmaceutici Details
2.24.2 Chiesi Farmaceutici Major Business
2.24.3 Chiesi Farmaceutici PDE Inhibitors Product and Services
2.24.4 Chiesi Farmaceutici PDE Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.25 Verona Pharma
2.25.1 Verona Pharma Details
2.25.2 Verona Pharma Major Business
2.25.3 Verona Pharma PDE Inhibitors Product and Services
2.25.4 Verona Pharma PDE Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 PDE INHIBITORS BREAKDOWN DATA BY MANUFACTURER
3.1 Global PDE Inhibitors Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global PDE Inhibitors Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in PDE Inhibitors
3.4 Market Concentration Rate
3.4.1 Top 3 PDE Inhibitors Manufacturer Market Share in 2021
3.4.2 Top 6 PDE Inhibitors Manufacturer Market Share in 2021
3.5 Global PDE Inhibitors Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and PDE Inhibitors Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 MARKET ANALYSIS BY REGION
4.1 Global PDE Inhibitors Market Size by Region
4.1.1 Global PDE Inhibitors Sales in Volume by Region (2017-2028)
4.1.2 Global PDE Inhibitors Revenue by Region (2017-2028)
4.2 North America PDE Inhibitors Revenue (2017-2028)
4.3 Europe PDE Inhibitors Revenue (2017-2028)
4.4 Asia-Pacific PDE Inhibitors Revenue (2017-2028)
4.5 South America PDE Inhibitors Revenue (2017-2028)
4.6 Middle East and Africa PDE Inhibitors Revenue (2017-2028)
5 MARKET SEGMENT BY TYPE
5.1 Global PDE Inhibitors Sales in Volume by Type (2017-2028)
5.2 Global PDE Inhibitors Revenue by Type (2017-2028)
5.3 Global PDE Inhibitors Price by Type (2017-2028)
6 MARKET SEGMENT BY APPLICATION
6.1 Global PDE Inhibitors Sales in Volume by Application (2017-2028)
6.2 Global PDE Inhibitors Revenue by Application (2017-2028)
6.3 Global PDE Inhibitors Price by Application (2017-2028)
7 NORTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
7.1 North America PDE Inhibitors Sales by Type (2017-2028)
7.2 North America PDE Inhibitors Sales by Application (2017-2028)
7.3 North America PDE Inhibitors Market Size by Country
7.3.1 North America PDE Inhibitors Sales in Volume by Country (2017-2028)
7.3.2 North America PDE Inhibitors Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 EUROPE BY COUNTRY, BY TYPE, AND BY APPLICATION
8.1 Europe PDE Inhibitors Sales by Type (2017-2028)
8.2 Europe PDE Inhibitors Sales by Application (2017-2028)
8.3 Europe PDE Inhibitors Market Size by Country
8.3.1 Europe PDE Inhibitors Sales in Volume by Country (2017-2028)
8.3.2 Europe PDE Inhibitors Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 ASIA-PACIFIC BY REGION, BY TYPE, AND BY APPLICATION
9.1 Asia-Pacific PDE Inhibitors Sales by Type (2017-2028)
9.2 Asia-Pacific PDE Inhibitors Sales by Application (2017-2028)
9.3 Asia-Pacific PDE Inhibitors Market Size by Region
9.3.1 Asia-Pacific PDE Inhibitors Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific PDE Inhibitors Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 SOUTH AMERICA BY REGION, BY TYPE, AND BY APPLICATION
10.1 South America PDE Inhibitors Sales by Type (2017-2028)
10.2 South America PDE Inhibitors Sales by Application (2017-2028)
10.3 South America PDE Inhibitors Market Size by Country
10.3.1 South America PDE Inhibitors Sales in Volume by Country (2017-2028)
10.3.2 South America PDE Inhibitors Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 MIDDLE EAST & AFRICA BY COUNTRY, BY TYPE, AND BY APPLICATION
11.1 Middle East & Africa PDE Inhibitors Sales by Type (2017-2028)
11.2 Middle East & Africa PDE Inhibitors Sales by Application (2017-2028)
11.3 Middle East & Africa PDE Inhibitors Market Size by Country
11.3.1 Middle East & Africa PDE Inhibitors Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa PDE Inhibitors Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 RAW MATERIAL AND INDUSTRY CHAIN
12.1 Raw Material of PDE Inhibitors and Key Manufacturers
12.2 Manufacturing Costs Percentage of PDE Inhibitors
12.3 PDE Inhibitors Production Process
12.4 PDE Inhibitors Industrial Chain
13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 PDE Inhibitors Typical Distributors
13.3 PDE Inhibitors Typical Customers
14 RESEARCH FINDINGS AND CONCLUSION
15 APPENDIX
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
1.1 PDE Inhibitors Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global PDE Inhibitors Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 PDE5
1.2.3 PDE4
1.2.4 Viagra
1.2.5 Cialis
1.2.6 Levitra
1.2.7 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global PDE Inhibitors Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Genitourinary
1.3.3 Cardiovascular Diseases
1.3.4 Dermatological Disorders
1.3.5 Respiratory Diseases
1.3.6 Schizophrenia
1.3.7 Alzheimer’S Disease
1.3.8 Huntington’S Disease
1.3.9 Others
1.4 Global PDE Inhibitors Market Size & Forecast
1.4.1 Global PDE Inhibitors Sales in Value (2017 & 2021 & 2028)
1.4.2 Global PDE Inhibitors Sales in Volume (2017-2028)
1.4.3 Global PDE Inhibitors Price (2017-2028)
1.5 Global PDE Inhibitors Production Capacity Analysis
1.5.1 Global PDE Inhibitors Total Production Capacity (2017-2028)
1.5.2 Global PDE Inhibitors Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 PDE Inhibitors Market Drivers
1.6.2 PDE Inhibitors Market Restraints
1.6.3 PDE Inhibitors Trends Analysis
2 MANUFACTURERS PROFILES
2.1 Hanmi Science Holding
2.1.1 Hanmi Science Holding Details
2.1.2 Hanmi Science Holding Major Business
2.1.3 Hanmi Science Holding PDE Inhibitors Product and Services
2.1.4 Hanmi Science Holding PDE Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Boehringer Ingelheim
2.2.1 Boehringer Ingelheim Details
2.2.2 Boehringer Ingelheim Major Business
2.2.3 Boehringer Ingelheim PDE Inhibitors Product and Services
2.2.4 Boehringer Ingelheim PDE Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Takeda Pharmaceuticals
2.3.1 Takeda Pharmaceuticals Details
2.3.2 Takeda Pharmaceuticals Major Business
2.3.3 Takeda Pharmaceuticals PDE Inhibitors Product and Services
2.3.4 Takeda Pharmaceuticals PDE Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 AstraZeneca
2.4.1 AstraZeneca Details
2.4.2 AstraZeneca Major Business
2.4.3 AstraZeneca PDE Inhibitors Product and Services
2.4.4 AstraZeneca PDE Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Bayer
2.5.1 Bayer Details
2.5.2 Bayer Major Business
2.5.3 Bayer PDE Inhibitors Product and Services
2.5.4 Bayer PDE Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Celgene
2.6.1 Celgene Details
2.6.2 Celgene Major Business
2.6.3 Celgene PDE Inhibitors Product and Services
2.6.4 Celgene PDE Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Eli Lilly
2.7.1 Eli Lilly Details
2.7.2 Eli Lilly Major Business
2.7.3 Eli Lilly PDE Inhibitors Product and Services
2.7.4 Eli Lilly PDE Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Pfizer
2.8.1 Pfizer Details
2.8.2 Pfizer Major Business
2.8.3 Pfizer PDE Inhibitors Product and Services
2.8.4 Pfizer PDE Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 BioCrea
2.9.1 BioCrea Details
2.9.2 BioCrea Major Business
2.9.3 BioCrea PDE Inhibitors Product and Services
2.9.4 BioCrea PDE Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Dart NeuroScience
2.10.1 Dart NeuroScience Details
2.10.2 Dart NeuroScience Major Business
2.10.3 Dart NeuroScience PDE Inhibitors Product and Services
2.10.4 Dart NeuroScience PDE Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Carinopharm
2.11.1 Carinopharm Details
2.11.2 Carinopharm Major Business
2.11.3 Carinopharm PDE Inhibitors Product and Services
2.11.4 Carinopharm PDE Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 CTC Bio
2.12.1 CTC Bio Details
2.12.2 CTC Bio Major Business
2.12.3 CTC Bio PDE Inhibitors Product and Services
2.12.4 CTC Bio PDE Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 FORUM Pharmaceuticals
2.13.1 FORUM Pharmaceuticals Details
2.13.2 FORUM Pharmaceuticals Major Business
2.13.3 FORUM Pharmaceuticals PDE Inhibitors Product and Services
2.13.4 FORUM Pharmaceuticals PDE Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Intra-Cellular Therapies
2.14.1 Intra-Cellular Therapies Details
2.14.2 Intra-Cellular Therapies Major Business
2.14.3 Intra-Cellular Therapies PDE Inhibitors Product and Services
2.14.4 Intra-Cellular Therapies PDE Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Omeros Corporation
2.15.1 Omeros Corporation Details
2.15.2 Omeros Corporation Major Business
2.15.3 Omeros Corporation PDE Inhibitors Product and Services
2.15.4 Omeros Corporation PDE Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Medimetriks Pharmaceuticals
2.16.1 Medimetriks Pharmaceuticals Details
2.16.2 Medimetriks Pharmaceuticals Major Business
2.16.3 Medimetriks Pharmaceuticals PDE Inhibitors Product and Services
2.16.4 Medimetriks Pharmaceuticals PDE Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17 NuSirt Biopharma
2.17.1 NuSirt Biopharma Details
2.17.2 NuSirt Biopharma Major Business
2.17.3 NuSirt Biopharma PDE Inhibitors Product and Services
2.17.4 NuSirt Biopharma PDE Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18 Palobiopharma
2.18.1 Palobiopharma Details
2.18.2 Palobiopharma Major Business
2.18.3 Palobiopharma PDE Inhibitors Product and Services
2.18.4 Palobiopharma PDE Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.19 Roivant Sciences
2.19.1 Roivant Sciences Details
2.19.2 Roivant Sciences Major Business
2.19.3 Roivant Sciences PDE Inhibitors Product and Services
2.19.4 Roivant Sciences PDE Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.20 Sagene Pharmaceuticals
2.20.1 Sagene Pharmaceuticals Details
2.20.2 Sagene Pharmaceuticals Major Business
2.20.3 Sagene Pharmaceuticals PDE Inhibitors Product and Services
2.20.4 Sagene Pharmaceuticals PDE Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.21 Tetra Discovery Partners
2.21.1 Tetra Discovery Partners Details
2.21.2 Tetra Discovery Partners Major Business
2.21.3 Tetra Discovery Partners PDE Inhibitors Product and Services
2.21.4 Tetra Discovery Partners PDE Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.22 Tritech Biopharm
2.22.1 Tritech Biopharm Details
2.22.2 Tritech Biopharm Major Business
2.22.3 Tritech Biopharm PDE Inhibitors Product and Services
2.22.4 Tritech Biopharm PDE Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.23 Otsuka
2.23.1 Otsuka Details
2.23.2 Otsuka Major Business
2.23.3 Otsuka PDE Inhibitors Product and Services
2.23.4 Otsuka PDE Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.24 Chiesi Farmaceutici
2.24.1 Chiesi Farmaceutici Details
2.24.2 Chiesi Farmaceutici Major Business
2.24.3 Chiesi Farmaceutici PDE Inhibitors Product and Services
2.24.4 Chiesi Farmaceutici PDE Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.25 Verona Pharma
2.25.1 Verona Pharma Details
2.25.2 Verona Pharma Major Business
2.25.3 Verona Pharma PDE Inhibitors Product and Services
2.25.4 Verona Pharma PDE Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 PDE INHIBITORS BREAKDOWN DATA BY MANUFACTURER
3.1 Global PDE Inhibitors Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global PDE Inhibitors Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in PDE Inhibitors
3.4 Market Concentration Rate
3.4.1 Top 3 PDE Inhibitors Manufacturer Market Share in 2021
3.4.2 Top 6 PDE Inhibitors Manufacturer Market Share in 2021
3.5 Global PDE Inhibitors Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and PDE Inhibitors Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 MARKET ANALYSIS BY REGION
4.1 Global PDE Inhibitors Market Size by Region
4.1.1 Global PDE Inhibitors Sales in Volume by Region (2017-2028)
4.1.2 Global PDE Inhibitors Revenue by Region (2017-2028)
4.2 North America PDE Inhibitors Revenue (2017-2028)
4.3 Europe PDE Inhibitors Revenue (2017-2028)
4.4 Asia-Pacific PDE Inhibitors Revenue (2017-2028)
4.5 South America PDE Inhibitors Revenue (2017-2028)
4.6 Middle East and Africa PDE Inhibitors Revenue (2017-2028)
5 MARKET SEGMENT BY TYPE
5.1 Global PDE Inhibitors Sales in Volume by Type (2017-2028)
5.2 Global PDE Inhibitors Revenue by Type (2017-2028)
5.3 Global PDE Inhibitors Price by Type (2017-2028)
6 MARKET SEGMENT BY APPLICATION
6.1 Global PDE Inhibitors Sales in Volume by Application (2017-2028)
6.2 Global PDE Inhibitors Revenue by Application (2017-2028)
6.3 Global PDE Inhibitors Price by Application (2017-2028)
7 NORTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
7.1 North America PDE Inhibitors Sales by Type (2017-2028)
7.2 North America PDE Inhibitors Sales by Application (2017-2028)
7.3 North America PDE Inhibitors Market Size by Country
7.3.1 North America PDE Inhibitors Sales in Volume by Country (2017-2028)
7.3.2 North America PDE Inhibitors Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 EUROPE BY COUNTRY, BY TYPE, AND BY APPLICATION
8.1 Europe PDE Inhibitors Sales by Type (2017-2028)
8.2 Europe PDE Inhibitors Sales by Application (2017-2028)
8.3 Europe PDE Inhibitors Market Size by Country
8.3.1 Europe PDE Inhibitors Sales in Volume by Country (2017-2028)
8.3.2 Europe PDE Inhibitors Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 ASIA-PACIFIC BY REGION, BY TYPE, AND BY APPLICATION
9.1 Asia-Pacific PDE Inhibitors Sales by Type (2017-2028)
9.2 Asia-Pacific PDE Inhibitors Sales by Application (2017-2028)
9.3 Asia-Pacific PDE Inhibitors Market Size by Region
9.3.1 Asia-Pacific PDE Inhibitors Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific PDE Inhibitors Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 SOUTH AMERICA BY REGION, BY TYPE, AND BY APPLICATION
10.1 South America PDE Inhibitors Sales by Type (2017-2028)
10.2 South America PDE Inhibitors Sales by Application (2017-2028)
10.3 South America PDE Inhibitors Market Size by Country
10.3.1 South America PDE Inhibitors Sales in Volume by Country (2017-2028)
10.3.2 South America PDE Inhibitors Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 MIDDLE EAST & AFRICA BY COUNTRY, BY TYPE, AND BY APPLICATION
11.1 Middle East & Africa PDE Inhibitors Sales by Type (2017-2028)
11.2 Middle East & Africa PDE Inhibitors Sales by Application (2017-2028)
11.3 Middle East & Africa PDE Inhibitors Market Size by Country
11.3.1 Middle East & Africa PDE Inhibitors Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa PDE Inhibitors Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 RAW MATERIAL AND INDUSTRY CHAIN
12.1 Raw Material of PDE Inhibitors and Key Manufacturers
12.2 Manufacturing Costs Percentage of PDE Inhibitors
12.3 PDE Inhibitors Production Process
12.4 PDE Inhibitors Industrial Chain
13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 PDE Inhibitors Typical Distributors
13.3 PDE Inhibitors Typical Customers
14 RESEARCH FINDINGS AND CONCLUSION
15 APPENDIX
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
LIST OF TABLES
Table 1. Global PDE Inhibitors Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global PDE Inhibitors Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Hanmi Science Holding Basic Information, Manufacturing Base and Competitors
Table 4. Hanmi Science Holding Major Business
Table 5. Hanmi Science Holding PDE Inhibitors Product and Services
Table 6. Hanmi Science Holding PDE Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 8. Boehringer Ingelheim Major Business
Table 9. Boehringer Ingelheim PDE Inhibitors Product and Services
Table 10. Boehringer Ingelheim PDE Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Takeda Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 12. Takeda Pharmaceuticals Major Business
Table 13. Takeda Pharmaceuticals PDE Inhibitors Product and Services
Table 14. Takeda Pharmaceuticals PDE Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 16. AstraZeneca Major Business
Table 17. AstraZeneca PDE Inhibitors Product and Services
Table 18. AstraZeneca PDE Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Bayer Basic Information, Manufacturing Base and Competitors
Table 20. Bayer Major Business
Table 21. Bayer PDE Inhibitors Product and Services
Table 22. Bayer PDE Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Celgene Basic Information, Manufacturing Base and Competitors
Table 24. Celgene Major Business
Table 25. Celgene PDE Inhibitors Product and Services
Table 26. Celgene PDE Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 28. Eli Lilly Major Business
Table 29. Eli Lilly PDE Inhibitors Product and Services
Table 30. Eli Lilly PDE Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Pfizer Basic Information, Manufacturing Base and Competitors
Table 32. Pfizer Major Business
Table 33. Pfizer PDE Inhibitors Product and Services
Table 34. Pfizer PDE Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. BioCrea Basic Information, Manufacturing Base and Competitors
Table 36. BioCrea Major Business
Table 37. BioCrea PDE Inhibitors Product and Services
Table 38. BioCrea PDE Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Dart NeuroScience Basic Information, Manufacturing Base and Competitors
Table 40. Dart NeuroScience Major Business
Table 41. Dart NeuroScience PDE Inhibitors Product and Services
Table 42. Dart NeuroScience PDE Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Carinopharm Basic Information, Manufacturing Base and Competitors
Table 44. Carinopharm Major Business
Table 45. Carinopharm PDE Inhibitors Product and Services
Table 46. Carinopharm PDE Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. CTC Bio Basic Information, Manufacturing Base and Competitors
Table 48. CTC Bio Major Business
Table 49. CTC Bio PDE Inhibitors Product and Services
Table 50. CTC Bio PDE Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. FORUM Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 52. FORUM Pharmaceuticals Major Business
Table 53. FORUM Pharmaceuticals PDE Inhibitors Product and Services
Table 54. FORUM Pharmaceuticals PDE Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Intra-Cellular Therapies Basic Information, Manufacturing Base and Competitors
Table 56. Intra-Cellular Therapies Major Business
Table 57. Intra-Cellular Therapies PDE Inhibitors Product and Services
Table 58. Intra-Cellular Therapies PDE Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Omeros Corporation Basic Information, Manufacturing Base and Competitors
Table 60. Omeros Corporation Major Business
Table 61. Omeros Corporation PDE Inhibitors Product and Services
Table 62. Omeros Corporation PDE Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Medimetriks Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 64. Medimetriks Pharmaceuticals Major Business
Table 65. Medimetriks Pharmaceuticals PDE Inhibitors Product and Services
Table 66. Medimetriks Pharmaceuticals PDE Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 67. NuSirt Biopharma Basic Information, Manufacturing Base and Competitors
Table 68. NuSirt Biopharma Major Business
Table 69. NuSirt Biopharma PDE Inhibitors Product and Services
Table 70. NuSirt Biopharma PDE Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 71. Palobiopharma Basic Information, Manufacturing Base and Competitors
Table 72. Palobiopharma Major Business
Table 73. Palobiopharma PDE Inhibitors Product and Services
Table 74. Palobiopharma PDE Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 75. Roivant Sciences Basic Information, Manufacturing Base and Competitors
Table 76. Roivant Sciences Major Business
Table 77. Roivant Sciences PDE Inhibitors Product and Services
Table 78. Roivant Sciences PDE Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 79. Sagene Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 80. Sagene Pharmaceuticals Major Business
Table 81. Sagene Pharmaceuticals PDE Inhibitors Product and Services
Table 82. Sagene Pharmaceuticals PDE Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 83. Tetra Discovery Partners Basic Information, Manufacturing Base and Competitors
Table 84. Tetra Discovery Partners Major Business
Table 85. Tetra Discovery Partners PDE Inhibitors Product and Services
Table 86. Tetra Discovery Partners PDE Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 87. Tritech Biopharm Basic Information, Manufacturing Base and Competitors
Table 88. Tritech Biopharm Major Business
Table 89. Tritech Biopharm PDE Inhibitors Product and Services
Table 90. Tritech Biopharm PDE Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 91. Otsuka Basic Information, Manufacturing Base and Competitors
Table 92. Otsuka Major Business
Table 93. Otsuka PDE Inhibitors Product and Services
Table 94. Otsuka PDE Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 95. Chiesi Farmaceutici Basic Information, Manufacturing Base and Competitors
Table 96. Chiesi Farmaceutici Major Business
Table 97. Chiesi Farmaceutici PDE Inhibitors Product and Services
Table 98. Chiesi Farmaceutici PDE Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 99. Verona Pharma Basic Information, Manufacturing Base and Competitors
Table 100. Verona Pharma Major Business
Table 101. Verona Pharma PDE Inhibitors Product and Services
Table 102. Verona Pharma PDE Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 103. Global PDE Inhibitors Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 104. Global PDE Inhibitors Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 105. Market Position of Manufacturers in PDE Inhibitors, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 106. Global PDE Inhibitors Production Capacity by Company, (K Units): 2020 VS 2021
Table 107. Head Office and PDE Inhibitors Production Site of Key Manufacturer
Table 108. PDE Inhibitors New Entrant and Capacity Expansion Plans
Table 109. PDE Inhibitors Mergers & Acquisitions in the Past Five Years
Table 110. Global PDE Inhibitors Sales by Region (2017-2022) & (K Units)
Table 111. Global PDE Inhibitors Sales by Region (2023-2028) & (K Units)
Table 112. Global PDE Inhibitors Revenue by Region (2017-2022) & (USD Million)
Table 113. Global PDE Inhibitors Revenue by Region (2023-2028) & (USD Million)
Table 114. Global PDE Inhibitors Sales by Type (2017-2022) & (K Units)
Table 115. Global PDE Inhibitors Sales by Type (2023-2028) & (K Units)
Table 116. Global PDE Inhibitors Revenue by Type (2017-2022) & (USD Million)
Table 117. Global PDE Inhibitors Revenue by Type (2023-2028) & (USD Million)
Table 118. Global PDE Inhibitors Price by Type (2017-2022) & (USD/Unit)
Table 119. Global PDE Inhibitors Price by Type (2023-2028) & (USD/Unit)
Table 120. Global PDE Inhibitors Sales by Application (2017-2022) & (K Units)
Table 121. Global PDE Inhibitors Sales by Application (2023-2028) & (K Units)
Table 122. Global PDE Inhibitors Revenue by Application (2017-2022) & (USD Million)
Table 123. Global PDE Inhibitors Revenue by Application (2023-2028) & (USD Million)
Table 124. Global PDE Inhibitors Price by Application (2017-2022) & (USD/Unit)
Table 125. Global PDE Inhibitors Price by Application (2023-2028) & (USD/Unit)
Table 126. North America PDE Inhibitors Sales by Country (2017-2022) & (K Units)
Table 127. North America PDE Inhibitors Sales by Country (2023-2028) & (K Units)
Table 128. North America PDE Inhibitors Revenue by Country (2017-2022) & (USD Million)
Table 129. North America PDE Inhibitors Revenue by Country (2023-2028) & (USD Million)
Table 130. North America PDE Inhibitors Sales by Type (2017-2022) & (K Units)
Table 131. North America PDE Inhibitors Sales by Type (2023-2028) & (K Units)
Table 132. North America PDE Inhibitors Sales by Application (2017-2022) & (K Units)
Table 133. North America PDE Inhibitors Sales by Application (2023-2028) & (K Units)
Table 134. Europe PDE Inhibitors Sales by Country (2017-2022) & (K Units)
Table 135. Europe PDE Inhibitors Sales by Country (2023-2028) & (K Units)
Table 136. Europe PDE Inhibitors Revenue by Country (2017-2022) & (USD Million)
Table 137. Europe PDE Inhibitors Revenue by Country (2023-2028) & (USD Million)
Table 138. Europe PDE Inhibitors Sales by Type (2017-2022) & (K Units)
Table 139. Europe PDE Inhibitors Sales by Type (2023-2028) & (K Units)
Table 140. Europe PDE Inhibitors Sales by Application (2017-2022) & (K Units)
Table 141. Europe PDE Inhibitors Sales by Application (2023-2028) & (K Units)
Table 142. Asia-Pacific PDE Inhibitors Sales by Region (2017-2022) & (K Units)
Table 143. Asia-Pacific PDE Inhibitors Sales by Region (2023-2028) & (K Units)
Table 144. Asia-Pacific PDE Inhibitors Revenue by Region (2017-2022) & (USD Million)
Table 145. Asia-Pacific PDE Inhibitors Revenue by Region (2023-2028) & (USD Million)
Table 146. Asia-Pacific PDE Inhibitors Sales by Type (2017-2022) & (K Units)
Table 147. Asia-Pacific PDE Inhibitors Sales by Type (2023-2028) & (K Units)
Table 148. Asia-Pacific PDE Inhibitors Sales by Application (2017-2022) & (K Units)
Table 149. Asia-Pacific PDE Inhibitors Sales by Application (2023-2028) & (K Units)
Table 150. South America PDE Inhibitors Sales by Country (2017-2022) & (K Units)
Table 151. South America PDE Inhibitors Sales by Country (2023-2028) & (K Units)
Table 152. South America PDE Inhibitors Revenue by Country (2017-2022) & (USD Million)
Table 153. South America PDE Inhibitors Revenue by Country (2023-2028) & (USD Million)
Table 154. South America PDE Inhibitors Sales by Type (2017-2022) & (K Units)
Table 155. South America PDE Inhibitors Sales by Type (2023-2028) & (K Units)
Table 156. South America PDE Inhibitors Sales by Application (2017-2022) & (K Units)
Table 157. South America PDE Inhibitors Sales by Application (2023-2028) & (K Units)
Table 158. Middle East & Africa PDE Inhibitors Sales by Region (2017-2022) & (K Units)
Table 159. Middle East & Africa PDE Inhibitors Sales by Region (2023-2028) & (K Units)
Table 160. Middle East & Africa PDE Inhibitors Revenue by Region (2017-2022) & (USD Million)
Table 161. Middle East & Africa PDE Inhibitors Revenue by Region (2023-2028) & (USD Million)
Table 162. Middle East & Africa PDE Inhibitors Sales by Type (2017-2022) & (K Units)
Table 163. Middle East & Africa PDE Inhibitors Sales by Type (2023-2028) & (K Units)
Table 164. Middle East & Africa PDE Inhibitors Sales by Application (2017-2022) & (K Units)
Table 165. Middle East & Africa PDE Inhibitors Sales by Application (2023-2028) & (K Units)
Table 166. PDE Inhibitors Raw Material
Table 167. Key Manufacturers of PDE Inhibitors Raw Materials
Table 168. Direct Channel Pros & Cons
Table 169. Indirect Channel Pros & Cons
Table 170. PDE Inhibitors Typical Distributors
Table 171. PDE Inhibitors Typical Customers
Table 1. Global PDE Inhibitors Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global PDE Inhibitors Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Hanmi Science Holding Basic Information, Manufacturing Base and Competitors
Table 4. Hanmi Science Holding Major Business
Table 5. Hanmi Science Holding PDE Inhibitors Product and Services
Table 6. Hanmi Science Holding PDE Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 8. Boehringer Ingelheim Major Business
Table 9. Boehringer Ingelheim PDE Inhibitors Product and Services
Table 10. Boehringer Ingelheim PDE Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Takeda Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 12. Takeda Pharmaceuticals Major Business
Table 13. Takeda Pharmaceuticals PDE Inhibitors Product and Services
Table 14. Takeda Pharmaceuticals PDE Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 16. AstraZeneca Major Business
Table 17. AstraZeneca PDE Inhibitors Product and Services
Table 18. AstraZeneca PDE Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Bayer Basic Information, Manufacturing Base and Competitors
Table 20. Bayer Major Business
Table 21. Bayer PDE Inhibitors Product and Services
Table 22. Bayer PDE Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Celgene Basic Information, Manufacturing Base and Competitors
Table 24. Celgene Major Business
Table 25. Celgene PDE Inhibitors Product and Services
Table 26. Celgene PDE Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 28. Eli Lilly Major Business
Table 29. Eli Lilly PDE Inhibitors Product and Services
Table 30. Eli Lilly PDE Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Pfizer Basic Information, Manufacturing Base and Competitors
Table 32. Pfizer Major Business
Table 33. Pfizer PDE Inhibitors Product and Services
Table 34. Pfizer PDE Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. BioCrea Basic Information, Manufacturing Base and Competitors
Table 36. BioCrea Major Business
Table 37. BioCrea PDE Inhibitors Product and Services
Table 38. BioCrea PDE Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Dart NeuroScience Basic Information, Manufacturing Base and Competitors
Table 40. Dart NeuroScience Major Business
Table 41. Dart NeuroScience PDE Inhibitors Product and Services
Table 42. Dart NeuroScience PDE Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Carinopharm Basic Information, Manufacturing Base and Competitors
Table 44. Carinopharm Major Business
Table 45. Carinopharm PDE Inhibitors Product and Services
Table 46. Carinopharm PDE Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. CTC Bio Basic Information, Manufacturing Base and Competitors
Table 48. CTC Bio Major Business
Table 49. CTC Bio PDE Inhibitors Product and Services
Table 50. CTC Bio PDE Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. FORUM Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 52. FORUM Pharmaceuticals Major Business
Table 53. FORUM Pharmaceuticals PDE Inhibitors Product and Services
Table 54. FORUM Pharmaceuticals PDE Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Intra-Cellular Therapies Basic Information, Manufacturing Base and Competitors
Table 56. Intra-Cellular Therapies Major Business
Table 57. Intra-Cellular Therapies PDE Inhibitors Product and Services
Table 58. Intra-Cellular Therapies PDE Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Omeros Corporation Basic Information, Manufacturing Base and Competitors
Table 60. Omeros Corporation Major Business
Table 61. Omeros Corporation PDE Inhibitors Product and Services
Table 62. Omeros Corporation PDE Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Medimetriks Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 64. Medimetriks Pharmaceuticals Major Business
Table 65. Medimetriks Pharmaceuticals PDE Inhibitors Product and Services
Table 66. Medimetriks Pharmaceuticals PDE Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 67. NuSirt Biopharma Basic Information, Manufacturing Base and Competitors
Table 68. NuSirt Biopharma Major Business
Table 69. NuSirt Biopharma PDE Inhibitors Product and Services
Table 70. NuSirt Biopharma PDE Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 71. Palobiopharma Basic Information, Manufacturing Base and Competitors
Table 72. Palobiopharma Major Business
Table 73. Palobiopharma PDE Inhibitors Product and Services
Table 74. Palobiopharma PDE Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 75. Roivant Sciences Basic Information, Manufacturing Base and Competitors
Table 76. Roivant Sciences Major Business
Table 77. Roivant Sciences PDE Inhibitors Product and Services
Table 78. Roivant Sciences PDE Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 79. Sagene Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 80. Sagene Pharmaceuticals Major Business
Table 81. Sagene Pharmaceuticals PDE Inhibitors Product and Services
Table 82. Sagene Pharmaceuticals PDE Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 83. Tetra Discovery Partners Basic Information, Manufacturing Base and Competitors
Table 84. Tetra Discovery Partners Major Business
Table 85. Tetra Discovery Partners PDE Inhibitors Product and Services
Table 86. Tetra Discovery Partners PDE Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 87. Tritech Biopharm Basic Information, Manufacturing Base and Competitors
Table 88. Tritech Biopharm Major Business
Table 89. Tritech Biopharm PDE Inhibitors Product and Services
Table 90. Tritech Biopharm PDE Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 91. Otsuka Basic Information, Manufacturing Base and Competitors
Table 92. Otsuka Major Business
Table 93. Otsuka PDE Inhibitors Product and Services
Table 94. Otsuka PDE Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 95. Chiesi Farmaceutici Basic Information, Manufacturing Base and Competitors
Table 96. Chiesi Farmaceutici Major Business
Table 97. Chiesi Farmaceutici PDE Inhibitors Product and Services
Table 98. Chiesi Farmaceutici PDE Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 99. Verona Pharma Basic Information, Manufacturing Base and Competitors
Table 100. Verona Pharma Major Business
Table 101. Verona Pharma PDE Inhibitors Product and Services
Table 102. Verona Pharma PDE Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 103. Global PDE Inhibitors Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 104. Global PDE Inhibitors Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 105. Market Position of Manufacturers in PDE Inhibitors, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 106. Global PDE Inhibitors Production Capacity by Company, (K Units): 2020 VS 2021
Table 107. Head Office and PDE Inhibitors Production Site of Key Manufacturer
Table 108. PDE Inhibitors New Entrant and Capacity Expansion Plans
Table 109. PDE Inhibitors Mergers & Acquisitions in the Past Five Years
Table 110. Global PDE Inhibitors Sales by Region (2017-2022) & (K Units)
Table 111. Global PDE Inhibitors Sales by Region (2023-2028) & (K Units)
Table 112. Global PDE Inhibitors Revenue by Region (2017-2022) & (USD Million)
Table 113. Global PDE Inhibitors Revenue by Region (2023-2028) & (USD Million)
Table 114. Global PDE Inhibitors Sales by Type (2017-2022) & (K Units)
Table 115. Global PDE Inhibitors Sales by Type (2023-2028) & (K Units)
Table 116. Global PDE Inhibitors Revenue by Type (2017-2022) & (USD Million)
Table 117. Global PDE Inhibitors Revenue by Type (2023-2028) & (USD Million)
Table 118. Global PDE Inhibitors Price by Type (2017-2022) & (USD/Unit)
Table 119. Global PDE Inhibitors Price by Type (2023-2028) & (USD/Unit)
Table 120. Global PDE Inhibitors Sales by Application (2017-2022) & (K Units)
Table 121. Global PDE Inhibitors Sales by Application (2023-2028) & (K Units)
Table 122. Global PDE Inhibitors Revenue by Application (2017-2022) & (USD Million)
Table 123. Global PDE Inhibitors Revenue by Application (2023-2028) & (USD Million)
Table 124. Global PDE Inhibitors Price by Application (2017-2022) & (USD/Unit)
Table 125. Global PDE Inhibitors Price by Application (2023-2028) & (USD/Unit)
Table 126. North America PDE Inhibitors Sales by Country (2017-2022) & (K Units)
Table 127. North America PDE Inhibitors Sales by Country (2023-2028) & (K Units)
Table 128. North America PDE Inhibitors Revenue by Country (2017-2022) & (USD Million)
Table 129. North America PDE Inhibitors Revenue by Country (2023-2028) & (USD Million)
Table 130. North America PDE Inhibitors Sales by Type (2017-2022) & (K Units)
Table 131. North America PDE Inhibitors Sales by Type (2023-2028) & (K Units)
Table 132. North America PDE Inhibitors Sales by Application (2017-2022) & (K Units)
Table 133. North America PDE Inhibitors Sales by Application (2023-2028) & (K Units)
Table 134. Europe PDE Inhibitors Sales by Country (2017-2022) & (K Units)
Table 135. Europe PDE Inhibitors Sales by Country (2023-2028) & (K Units)
Table 136. Europe PDE Inhibitors Revenue by Country (2017-2022) & (USD Million)
Table 137. Europe PDE Inhibitors Revenue by Country (2023-2028) & (USD Million)
Table 138. Europe PDE Inhibitors Sales by Type (2017-2022) & (K Units)
Table 139. Europe PDE Inhibitors Sales by Type (2023-2028) & (K Units)
Table 140. Europe PDE Inhibitors Sales by Application (2017-2022) & (K Units)
Table 141. Europe PDE Inhibitors Sales by Application (2023-2028) & (K Units)
Table 142. Asia-Pacific PDE Inhibitors Sales by Region (2017-2022) & (K Units)
Table 143. Asia-Pacific PDE Inhibitors Sales by Region (2023-2028) & (K Units)
Table 144. Asia-Pacific PDE Inhibitors Revenue by Region (2017-2022) & (USD Million)
Table 145. Asia-Pacific PDE Inhibitors Revenue by Region (2023-2028) & (USD Million)
Table 146. Asia-Pacific PDE Inhibitors Sales by Type (2017-2022) & (K Units)
Table 147. Asia-Pacific PDE Inhibitors Sales by Type (2023-2028) & (K Units)
Table 148. Asia-Pacific PDE Inhibitors Sales by Application (2017-2022) & (K Units)
Table 149. Asia-Pacific PDE Inhibitors Sales by Application (2023-2028) & (K Units)
Table 150. South America PDE Inhibitors Sales by Country (2017-2022) & (K Units)
Table 151. South America PDE Inhibitors Sales by Country (2023-2028) & (K Units)
Table 152. South America PDE Inhibitors Revenue by Country (2017-2022) & (USD Million)
Table 153. South America PDE Inhibitors Revenue by Country (2023-2028) & (USD Million)
Table 154. South America PDE Inhibitors Sales by Type (2017-2022) & (K Units)
Table 155. South America PDE Inhibitors Sales by Type (2023-2028) & (K Units)
Table 156. South America PDE Inhibitors Sales by Application (2017-2022) & (K Units)
Table 157. South America PDE Inhibitors Sales by Application (2023-2028) & (K Units)
Table 158. Middle East & Africa PDE Inhibitors Sales by Region (2017-2022) & (K Units)
Table 159. Middle East & Africa PDE Inhibitors Sales by Region (2023-2028) & (K Units)
Table 160. Middle East & Africa PDE Inhibitors Revenue by Region (2017-2022) & (USD Million)
Table 161. Middle East & Africa PDE Inhibitors Revenue by Region (2023-2028) & (USD Million)
Table 162. Middle East & Africa PDE Inhibitors Sales by Type (2017-2022) & (K Units)
Table 163. Middle East & Africa PDE Inhibitors Sales by Type (2023-2028) & (K Units)
Table 164. Middle East & Africa PDE Inhibitors Sales by Application (2017-2022) & (K Units)
Table 165. Middle East & Africa PDE Inhibitors Sales by Application (2023-2028) & (K Units)
Table 166. PDE Inhibitors Raw Material
Table 167. Key Manufacturers of PDE Inhibitors Raw Materials
Table 168. Direct Channel Pros & Cons
Table 169. Indirect Channel Pros & Cons
Table 170. PDE Inhibitors Typical Distributors
Table 171. PDE Inhibitors Typical Customers
LIST OF FIGURES
Figure 1. PDE Inhibitors Picture
Figure 2. Global PDE Inhibitors Revenue Market Share by Type in 2021
Figure 3. PDE5
Figure 4. PDE4
Figure 5. Viagra
Figure 6. Cialis
Figure 7. Levitra
Figure 8. Others
Figure 9. Global PDE Inhibitors Revenue Market Share by Application in 2021
Figure 10. Genitourinary
Figure 11. Cardiovascular Diseases
Figure 12. Dermatological Disorders
Figure 13. Respiratory Diseases
Figure 14. Schizophrenia
Figure 15. Alzheimer’S Disease
Figure 16. Huntington’S Disease
Figure 17. Others
Figure 18. Global PDE Inhibitors Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 19. Global PDE Inhibitors Revenue and Forecast (2017-2028) & (USD Million)
Figure 20. Global PDE Inhibitors Sales (2017-2028) & (K Units)
Figure 21. Global PDE Inhibitors Price (2017-2028) & (USD/Unit)
Figure 22. Global PDE Inhibitors Production Capacity (2017-2028) & (K Units)
Figure 23. Global PDE Inhibitors Production Capacity by Geographic Region: 2022 VS 2028
Figure 24. PDE Inhibitors Market Drivers
Figure 25. PDE Inhibitors Market Restraints
Figure 26. PDE Inhibitors Market Trends
Figure 27. Global PDE Inhibitors Sales Market Share by Manufacturer in 2021
Figure 28. Global PDE Inhibitors Revenue Market Share by Manufacturer in 2021
Figure 29. PDE Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 30. Top 3 PDE Inhibitors Manufacturer (Revenue) Market Share in 2021
Figure 31. Top 6 PDE Inhibitors Manufacturer (Revenue) Market Share in 2021
Figure 32. Global PDE Inhibitors Sales Market Share by Region (2017-2028)
Figure 33. Global PDE Inhibitors Revenue Market Share by Region (2017-2028)
Figure 34. North America PDE Inhibitors Revenue (2017-2028) & (USD Million)
Figure 35. Europe PDE Inhibitors Revenue (2017-2028) & (USD Million)
Figure 36. Asia-Pacific PDE Inhibitors Revenue (2017-2028) & (USD Million)
Figure 37. South America PDE Inhibitors Revenue (2017-2028) & (USD Million)
Figure 38. Middle East & Africa PDE Inhibitors Revenue (2017-2028) & (USD Million)
Figure 39. Global PDE Inhibitors Sales Market Share by Type (2017-2028)
Figure 40. Global PDE Inhibitors Revenue Market Share by Type (2017-2028)
Figure 41. Global PDE Inhibitors Price by Type (2017-2028) & (USD/Unit)
Figure 42. Global PDE Inhibitors Sales Market Share by Application (2017-2028)
Figure 43. Global PDE Inhibitors Revenue Market Share by Application (2017-2028)
Figure 44. Global PDE Inhibitors Price by Application (2017-2028) & (USD/Unit)
Figure 45. North America PDE Inhibitors Sales Market Share by Type (2017-2028)
Figure 46. North America PDE Inhibitors Sales Market Share by Application (2017-2028)
Figure 47. North America PDE Inhibitors Sales Market Share by Country (2017-2028)
Figure 48. North America PDE Inhibitors Revenue Market Share by Country (2017-2028)
Figure 49. United States PDE Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Canada PDE Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Mexico PDE Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Europe PDE Inhibitors Sales Market Share by Type (2017-2028)
Figure 53. Europe PDE Inhibitors Sales Market Share by Application (2017-2028)
Figure 54. Europe PDE Inhibitors Sales Market Share by Country (2017-2028)
Figure 55. Europe PDE Inhibitors Revenue Market Share by Country (2017-2028)
Figure 56. Germany PDE Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. France PDE Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. United Kingdom PDE Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Russia PDE Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Italy PDE Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Asia-Pacific PDE Inhibitors Sales Market Share by Region (2017-2028)
Figure 62. Asia-Pacific PDE Inhibitors Sales Market Share by Application (2017-2028)
Figure 63. Asia-Pacific PDE Inhibitors Sales Market Share by Region (2017-2028)
Figure 64. Asia-Pacific PDE Inhibitors Revenue Market Share by Region (2017-2028)
Figure 65. China PDE Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Japan PDE Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Korea PDE Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. India PDE Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Southeast Asia PDE Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Australia PDE Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. South America PDE Inhibitors Sales Market Share by Type (2017-2028)
Figure 72. South America PDE Inhibitors Sales Market Share by Application (2017-2028)
Figure 73. South America PDE Inhibitors Sales Market Share by Country (2017-2028)
Figure 74. South America PDE Inhibitors Revenue Market Share by Country (2017-2028)
Figure 75. Brazil PDE Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Argentina PDE Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Middle East & Africa PDE Inhibitors Sales Market Share by Type (2017-2028)
Figure 78. Middle East & Africa PDE Inhibitors Sales Market Share by Application (2017-2028)
Figure 79. Middle East & Africa PDE Inhibitors Sales Market Share by Region (2017-2028)
Figure 80. Middle East & Africa PDE Inhibitors Revenue Market Share by Region (2017-2028)
Figure 81. Turkey PDE Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 82. Egypt PDE Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 83. Saudi Arabia PDE Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 84. South Africa PDE Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 85. Manufacturing Cost Structure Analysis of PDE Inhibitors in 2021
Figure 86. Manufacturing Process Analysis of PDE Inhibitors
Figure 87. PDE Inhibitors Industrial Chain
Figure 88. Sales Channel: Direct Channel vs Indirect Channel
Figure 89. Methodology
Figure 90. Research Process and Data Source
Figure 1. PDE Inhibitors Picture
Figure 2. Global PDE Inhibitors Revenue Market Share by Type in 2021
Figure 3. PDE5
Figure 4. PDE4
Figure 5. Viagra
Figure 6. Cialis
Figure 7. Levitra
Figure 8. Others
Figure 9. Global PDE Inhibitors Revenue Market Share by Application in 2021
Figure 10. Genitourinary
Figure 11. Cardiovascular Diseases
Figure 12. Dermatological Disorders
Figure 13. Respiratory Diseases
Figure 14. Schizophrenia
Figure 15. Alzheimer’S Disease
Figure 16. Huntington’S Disease
Figure 17. Others
Figure 18. Global PDE Inhibitors Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 19. Global PDE Inhibitors Revenue and Forecast (2017-2028) & (USD Million)
Figure 20. Global PDE Inhibitors Sales (2017-2028) & (K Units)
Figure 21. Global PDE Inhibitors Price (2017-2028) & (USD/Unit)
Figure 22. Global PDE Inhibitors Production Capacity (2017-2028) & (K Units)
Figure 23. Global PDE Inhibitors Production Capacity by Geographic Region: 2022 VS 2028
Figure 24. PDE Inhibitors Market Drivers
Figure 25. PDE Inhibitors Market Restraints
Figure 26. PDE Inhibitors Market Trends
Figure 27. Global PDE Inhibitors Sales Market Share by Manufacturer in 2021
Figure 28. Global PDE Inhibitors Revenue Market Share by Manufacturer in 2021
Figure 29. PDE Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 30. Top 3 PDE Inhibitors Manufacturer (Revenue) Market Share in 2021
Figure 31. Top 6 PDE Inhibitors Manufacturer (Revenue) Market Share in 2021
Figure 32. Global PDE Inhibitors Sales Market Share by Region (2017-2028)
Figure 33. Global PDE Inhibitors Revenue Market Share by Region (2017-2028)
Figure 34. North America PDE Inhibitors Revenue (2017-2028) & (USD Million)
Figure 35. Europe PDE Inhibitors Revenue (2017-2028) & (USD Million)
Figure 36. Asia-Pacific PDE Inhibitors Revenue (2017-2028) & (USD Million)
Figure 37. South America PDE Inhibitors Revenue (2017-2028) & (USD Million)
Figure 38. Middle East & Africa PDE Inhibitors Revenue (2017-2028) & (USD Million)
Figure 39. Global PDE Inhibitors Sales Market Share by Type (2017-2028)
Figure 40. Global PDE Inhibitors Revenue Market Share by Type (2017-2028)
Figure 41. Global PDE Inhibitors Price by Type (2017-2028) & (USD/Unit)
Figure 42. Global PDE Inhibitors Sales Market Share by Application (2017-2028)
Figure 43. Global PDE Inhibitors Revenue Market Share by Application (2017-2028)
Figure 44. Global PDE Inhibitors Price by Application (2017-2028) & (USD/Unit)
Figure 45. North America PDE Inhibitors Sales Market Share by Type (2017-2028)
Figure 46. North America PDE Inhibitors Sales Market Share by Application (2017-2028)
Figure 47. North America PDE Inhibitors Sales Market Share by Country (2017-2028)
Figure 48. North America PDE Inhibitors Revenue Market Share by Country (2017-2028)
Figure 49. United States PDE Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Canada PDE Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Mexico PDE Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Europe PDE Inhibitors Sales Market Share by Type (2017-2028)
Figure 53. Europe PDE Inhibitors Sales Market Share by Application (2017-2028)
Figure 54. Europe PDE Inhibitors Sales Market Share by Country (2017-2028)
Figure 55. Europe PDE Inhibitors Revenue Market Share by Country (2017-2028)
Figure 56. Germany PDE Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. France PDE Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. United Kingdom PDE Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Russia PDE Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Italy PDE Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Asia-Pacific PDE Inhibitors Sales Market Share by Region (2017-2028)
Figure 62. Asia-Pacific PDE Inhibitors Sales Market Share by Application (2017-2028)
Figure 63. Asia-Pacific PDE Inhibitors Sales Market Share by Region (2017-2028)
Figure 64. Asia-Pacific PDE Inhibitors Revenue Market Share by Region (2017-2028)
Figure 65. China PDE Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Japan PDE Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Korea PDE Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. India PDE Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Southeast Asia PDE Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Australia PDE Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. South America PDE Inhibitors Sales Market Share by Type (2017-2028)
Figure 72. South America PDE Inhibitors Sales Market Share by Application (2017-2028)
Figure 73. South America PDE Inhibitors Sales Market Share by Country (2017-2028)
Figure 74. South America PDE Inhibitors Revenue Market Share by Country (2017-2028)
Figure 75. Brazil PDE Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Argentina PDE Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Middle East & Africa PDE Inhibitors Sales Market Share by Type (2017-2028)
Figure 78. Middle East & Africa PDE Inhibitors Sales Market Share by Application (2017-2028)
Figure 79. Middle East & Africa PDE Inhibitors Sales Market Share by Region (2017-2028)
Figure 80. Middle East & Africa PDE Inhibitors Revenue Market Share by Region (2017-2028)
Figure 81. Turkey PDE Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 82. Egypt PDE Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 83. Saudi Arabia PDE Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 84. South Africa PDE Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 85. Manufacturing Cost Structure Analysis of PDE Inhibitors in 2021
Figure 86. Manufacturing Process Analysis of PDE Inhibitors
Figure 87. PDE Inhibitors Industrial Chain
Figure 88. Sales Channel: Direct Channel vs Indirect Channel
Figure 89. Methodology
Figure 90. Research Process and Data Source
